Sangamo Therapeutics, Inc. (SGMOQ)
0.1554
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Sangamo Therapeutics Gross Profit (TTM) : 28.00M for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 28.00M |
| December 31, 2025 | 31.95M |
| September 30, 2025 | 25.02M |
| June 30, 2025 | 73.62M |
| March 31, 2025 | 55.00M |
| December 31, 2024 | 48.44M |
| September 30, 2024 | 42.08M |
| June 30, 2024 | -5.315M |
| March 31, 2024 | -0.519M |
| December 31, 2023 | 155.99M |
| September 30, 2023 | 180.82M |
| June 30, 2023 | 204.34M |
| March 31, 2023 | 228.26M |
| December 31, 2022 | 99.19M |
| September 30, 2022 | 100.53M |
| June 30, 2022 | 77.12M |
| March 31, 2022 | 50.62M |
| December 31, 2021 | 25.22M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |
| Vicapsys Life Sciences, Inc. | 0.00 |